Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): trial results and interleukin-6 analysis: a study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium.

Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): trial results and interleukin-6 analysis: a study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium. Cancer. 2009 Dec 01; 115(23):5541-9.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Androgen Antagonists
Antineoplastic Agents
Drug Resistance, Neoplasm
Enzyme Inhibitors
Histone Deacetylase Inhibitors
Humans
Hydroxamic Acids
Interleukin-6
Male
Middle Aged
Prostatic Neoplasms
Survival Analysis

authors with profiles

Walter M. Stadler